If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

A more-nuanced approach to reporting and interpreting data from randomized controlled trials, one that factors in the totality of the evidence, is warranted in cardiovascular medicine, according to a ...

The pursuit of science is designed to search for significance in a maze of data. At least, that’s how it’s supposed to work. To support or refute a hypothesis, the goal is to establish statistical ...

WASHINGTON – This year's edition of Transcatheter Cardiovascular Therapeutics offered a host of sessions addressing clinical trial design and data, but one of the more thought-provoking sessions may ...

A little over a decade ago, a neuroscientist found "significant activation" in the neural tissue of a dead fish. While it ...

Your editorial “The FDA Returns to Its Bad Habits” (Feb. 21) explains, “Reata’s p-value was 0.014, which means there was a 1.4% chance that its positive result was a fluke.” A related, true statement ...